- Home
- AVIR vs ACRE Comparison
AVIR vs ACRE Comparison
Compare AVIR & ACRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVIR
- ACRE
- Stock Information
- Founded
- AVIR 2012
- ACRE 2011
- Country
- AVIR United States
- ACRE United States
- Employees
- AVIR N/A
- ACRE N/A
- Industry
- AVIR Medicinal Chemicals and Botanical Products
- ACRE Real Estate Investment Trusts
- Sector
- AVIR Health Care
- ACRE Real Estate
- Exchange
- AVIR Nasdaq
- ACRE Nasdaq
- Market Cap
- AVIR 273.0M
- ACRE 264.6M
- IPO Year
- AVIR 2020
- ACRE 2012
- Fundamental
- Price
- AVIR $3.90
- ACRE $4.66
- Analyst Decision
- AVIR Hold
- ACRE Hold
- Analyst Count
- AVIR 1
- ACRE 6
- Target Price
- AVIR $6.00
- ACRE $5.58
- AVG Volume (30 Days)
- AVIR 426.9K
- ACRE 399.9K
- Earning Date
- AVIR 08-06-2025
- ACRE 08-05-2025
- Dividend Yield
- AVIR N/A
- ACRE 12.88%
- EPS Growth
- AVIR N/A
- ACRE N/A
- EPS
- AVIR N/A
- ACRE N/A
- Revenue
- AVIR N/A
- ACRE $67,129,000.00
- Revenue This Year
- AVIR N/A
- ACRE N/A
- Revenue Next Year
- AVIR N/A
- ACRE N/A
- P/E Ratio
- AVIR N/A
- ACRE N/A
- Revenue Growth
- AVIR N/A
- ACRE 83.51
- 52 Week Low
- AVIR $2.46
- ACRE $3.35
- 52 Week High
- AVIR $4.15
- ACRE $7.89
- Technical
- Relative Strength Index (RSI)
- AVIR 67.66
- ACRE 48.67
- Support Level
- AVIR $3.36
- ACRE $4.39
- Resistance Level
- AVIR $3.53
- ACRE $4.68
- Average True Range (ATR)
- AVIR 0.15
- ACRE 0.13
- MACD
- AVIR -0.00
- ACRE -0.01
- Stochastic Oscillator
- AVIR 97.24
- ACRE 54.00
About AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing antiviral therapeutics to improve the lives of patients suffering from serious viral infections. The company is developing its product candidate, bemnifosbuvir, for the treatment of COVID-19, the disease caused by infection with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and its variants and also developing bemnifosbuvir in combination with ruzasvir for the treatment of Hepatitis C (HCV).
About ACRE Ares Commercial Real Estate Corporation
Ares Commercial Real Estate Corp is a specialty finance company and a Real Estate Investment Trust providing commercial real estate loans and related investments. It operates in one segment namely originating and managing a diversified portfolio of CRE debt-related investments. The group recognizes its revenues through the interest income it receives from loans.